CN106344210B - 涂药覆膜支架 - Google Patents
涂药覆膜支架 Download PDFInfo
- Publication number
- CN106344210B CN106344210B CN201611024468.XA CN201611024468A CN106344210B CN 106344210 B CN106344210 B CN 106344210B CN 201611024468 A CN201611024468 A CN 201611024468A CN 106344210 B CN106344210 B CN 106344210B
- Authority
- CN
- China
- Prior art keywords
- overlay film
- rack body
- area
- bare bracket
- coating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011248 coating agent Substances 0.000 title claims abstract description 91
- 238000000576 coating method Methods 0.000 title claims abstract description 91
- 239000012528 membrane Substances 0.000 claims abstract description 49
- 239000003814 drug Substances 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 16
- 238000013508 migration Methods 0.000 claims abstract description 6
- 229910045601 alloy Inorganic materials 0.000 claims description 8
- 239000000956 alloy Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 238000010147 laser engraving Methods 0.000 claims description 6
- 230000003463 hyperproliferative effect Effects 0.000 claims description 4
- 230000005012 migration Effects 0.000 claims description 4
- 210000000663 muscle cell Anatomy 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 25
- 208000037803 restenosis Diseases 0.000 abstract description 16
- 238000005452 bending Methods 0.000 abstract description 11
- 208000007536 Thrombosis Diseases 0.000 abstract description 10
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract description 6
- 230000010100 anticoagulation Effects 0.000 abstract description 5
- 230000004663 cell proliferation Effects 0.000 abstract description 4
- 230000012292 cell migration Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000002980 postoperative effect Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 description 11
- 210000004204 blood vessel Anatomy 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000005507 spraying Methods 0.000 description 9
- 229920000669 heparin Polymers 0.000 description 8
- 229960002897 heparin Drugs 0.000 description 7
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- 229930012538 Paclitaxel Natural products 0.000 description 5
- 230000001464 adherent effect Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229960001592 paclitaxel Drugs 0.000 description 5
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 239000012159 carrier gas Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 4
- 229960002930 sirolimus Drugs 0.000 description 4
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000009194 climbing Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003090 iliac artery Anatomy 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002406 microsurgery Methods 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000025494 Aortic disease Diseases 0.000 description 1
- 208000018672 Dilatation Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010072563 Peripheral artery stenosis Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 230000008069 intimal proliferation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 210000000107 myocyte Anatomy 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229920001690 polydopamine Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611024468.XA CN106344210B (zh) | 2016-11-17 | 2016-11-17 | 涂药覆膜支架 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611024468.XA CN106344210B (zh) | 2016-11-17 | 2016-11-17 | 涂药覆膜支架 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106344210A CN106344210A (zh) | 2017-01-25 |
CN106344210B true CN106344210B (zh) | 2018-05-22 |
Family
ID=57862646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611024468.XA Active CN106344210B (zh) | 2016-11-17 | 2016-11-17 | 涂药覆膜支架 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344210B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108969148B (zh) * | 2017-06-05 | 2024-04-23 | 深圳市健心医疗科技有限公司 | 医用覆膜支架 |
CN109419568B (zh) * | 2017-08-28 | 2023-09-19 | 先健科技(深圳)有限公司 | 覆膜支架 |
CN109419567A (zh) | 2017-08-28 | 2019-03-05 | 先健科技(深圳)有限公司 | 管腔支架 |
CN109419570B (zh) * | 2017-08-30 | 2024-05-24 | 先健科技(深圳)有限公司 | 覆膜支架及其制备方法 |
CN209499979U (zh) * | 2017-12-01 | 2019-10-18 | 杭州唯强医疗科技有限公司 | 高顺应性覆膜支架 |
CN108371572B (zh) * | 2018-02-11 | 2023-12-12 | 浙江巴泰医疗科技有限公司 | 一种螺旋型自膨胀支架 |
CN108378964A (zh) * | 2018-04-28 | 2018-08-10 | 上海脉全医疗器械有限公司 | 一种药物球囊 |
CN109602523B (zh) * | 2019-01-03 | 2024-02-09 | 科塞尔医疗科技(苏州)有限公司 | 一种可回收的药物支架 |
CN112891019B (zh) * | 2019-12-03 | 2022-09-20 | 深圳市先健畅通医疗有限公司 | 覆膜支架 |
CN113040988B (zh) * | 2019-12-26 | 2023-06-16 | 先健科技(深圳)有限公司 | 血管支架 |
CN115517833A (zh) * | 2022-06-24 | 2022-12-27 | 江苏朴芃医疗科技有限公司 | 血管覆膜支架及其制作方法及覆膜支架输送*** |
CN118304056A (zh) * | 2023-01-09 | 2024-07-09 | 杭州启明医疗器械股份有限公司 | 防周漏人工心脏瓣膜 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009002827A2 (en) * | 2007-06-22 | 2008-12-31 | Cr Bard Inc | Helical and segmented stent-graft |
CN102335052A (zh) * | 2011-07-15 | 2012-02-01 | 南京微创医学科技有限公司 | 抗再狭窄消化道内支架 |
CN203059974U (zh) * | 2013-01-24 | 2013-07-17 | 威海维心医疗设备有限公司 | 颅内自膨胀阶段覆膜编织支架 |
CN104434352B (zh) * | 2014-12-14 | 2016-08-17 | 韩新巍 | 一种顺应性可回收气道覆膜内支架及其制作方法 |
CN205073073U (zh) * | 2015-10-16 | 2016-03-09 | 李选 | 间断覆膜支架 |
CN105963051B (zh) * | 2016-04-20 | 2018-01-19 | 东华大学 | 一种具有局部耐久结构的血管支架织物覆膜及其制备方法 |
-
2016
- 2016-11-17 CN CN201611024468.XA patent/CN106344210B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106344210A (zh) | 2017-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106344210B (zh) | 涂药覆膜支架 | |
CN105744965B (zh) | 抗血栓产生的医疗装置和方法 | |
EP3158977B1 (en) | Stent manufacturing method | |
CN2817770Y (zh) | 礼帽型主动脉覆膜支架 | |
US8778011B2 (en) | Soft crowns | |
CN100352406C (zh) | 组合式可任意方向弯曲的覆膜支架 | |
CN201026247Y (zh) | 人工血管与人工支架血管的复合体 | |
CN101745153B (zh) | 具有全生物降解药物涂层的钴铬合金动脉支架、支架***及其制备方法 | |
CN2822554Y (zh) | 避免移位的无缝合线的血管覆膜支架 | |
CN101785900B (zh) | 一种药物球囊导管的制备方法 | |
CN1290152A (zh) | 不形成血栓的移植片固定模护套 | |
AU2012219950A1 (en) | Implant comprising a non-woven fabric | |
CN101703812B (zh) | 一种聚酰胺66覆膜镍钛合金血管支架及其制备方法 | |
BR112016006071B1 (pt) | Enxerto vascular artificial e método para a produção de um enxerto vascular artificial | |
CN206836995U (zh) | 涂药覆膜支架 | |
CN206761796U (zh) | 支架*** | |
WO2015090237A1 (zh) | 管道支架及其制备方法 | |
CN101632606A (zh) | 一种携载药物的介入医疗器械 | |
CN107874801A (zh) | 血管吻合器 | |
CN2635119Y (zh) | 一种带支撑的人造血管 | |
CN2675083Y (zh) | Y型大动脉覆膜支架 | |
CN207085001U (zh) | 一种可降解覆膜支架 | |
CN201643340U (zh) | 药物球囊导管 | |
CN108289746A (zh) | 可植入式腔内假体 | |
TWI688412B (zh) | 具支架的血液導管 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 311100 floor 1 and 2, building 1, No. 18, Keji Avenue, Yuhang street, Yuhang District, Hangzhou City, Zhejiang Province Patentee after: Guichuang Tongqiao Medical Technology Co.,Ltd. Address before: 311100 floor 1 and 2, building 1, No. 18, Keji Avenue, Yuhang street, Yuhang District, Hangzhou City, Zhejiang Province Patentee before: ZHEJIANG BELONGS TO A MEDICAL INSTRUMENT Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicated covered stent Granted publication date: 20180522 Pledgee: Zhejiang Hangzhou Yuhang Rural Commercial Bank Co.,Ltd. Science and Technology City Branch Pledgor: Guichuang Tongqiao Medical Technology Co.,Ltd. Registration number: Y2024980011819 |